This month, the BC Centre on Substance Use will hold the first in its new public lecture series called the Tracey Morrison Public Lecture: Speakers of Substance. These lectures will be a platform for important voices in substance use practice and policy: those with lived experience with substance use alongside those who bring research and clinical expertise.

Mark your calendars! Heart + Lung Health FEST 2019 will take place February 6-9 at the Pinnacle Hotel Harbourfront.

Eleven diverse and dedicated teams of point-of-care clinicians have received funding in this year's competition.

This year, five PHC teams were funded, two of them regional projects that will be jointly funded by PHC, PHCRI and VCH Research Institute.

For the first time in its eight-year history, the prestigious Margolese National Heart Disorders Prize is being shared by two recipients – and both are Providence-affiliated researchers.

This free public lecture is hosted by Dr. Michael Hayden, Centre for Molecular Medicine and Therapeutics, University of British Columbia.

Dr. Karin Humphries and her team want to improve health outcomes for women with suspected heart disease. Their “CODE-MI” study is one of several PHC research projects that were successful in the recent CIHR Spring Project Grant competition.

Permanent lung damage caused by chronic obstructive pulmonary disease (COPD) starts much earlier than previously thought, even before patients are showing symptoms.

The CEO of the PROOF Centre has received one of the country's highest civilian honours for his outstanding research.

Al Fowler, Board Member, BC Association of People on Methadone, and Peer Research Assistant, BC Centre on Substance Use, is the featured guest at the next edition of this lunch-time series hosted by the BCCSU.

Funded studies will investigate how to make the ED safer for patients and staff, and whether a virus might be the key to improving lung cancer treatments.

Dr. Don Sin will assume the role of Director of the Centre for Heart Lung Innovation at St. Paul’s Hospital (also known as the UBC James Hogg Research Centre), effective July 1, 2018.

You’re invited to hear the teams participating in this year’s PHC Practice-Based Research Challenge present their proposals for funding. This annual competition is open to point-of-care PHC staff and offers teams the opportunity to work with a mentor to develop a research proposal around a research question. 

RSVP to Wilma Chang: wchang@providencehealth.bc.ca. See the attached poster for event details.

The Michael Smith Foundation for Health Research recently announced the winners of its 2018 Scholar competition and six of the 17 award recipients are PHC-affiliated researchers.

SAVE BC physicians Dr. Simon Pimstone and Dr. Liam Brunham will present updates on the SAVE BC research program and genetics in heart disease. Dr. Tara Sedlak, director of the Leslie Diamond Women’s Heart Health Clinic, will speak about women and heart disease and Dr. John Mancini, director of the CardioRisk Clinic, will discuss management of cholesterol-related heart disease. 

Click here for event details.

Research coordinators are invited to attend the next installment of the Clinical Research Education Lunch & Learn Series, hosted by CHÉOS. Marx Jayaraman, project manager and CRA, CHÉOS & CTN, will speak on “Risk Based Monitoring” and Leslie Love, senior project manager, CHÉOS & CTN, will speak about the “Ask Me” campaign. Please bring your lunch.

Dr. Shira Goldenberg, a research scientist at the BC Centre for Excellence in HIV/AIDS, will speak on the topic of “Migration-related determinants of HIV and sexual health among marginalized women” at the next HIV Care Rounds lecture, hosted by the BC-CfE.

See the event page for details and to register.

The BC Centre on Substance Use hosts the fifth annual Addiction Research Day, a free event featuring oral and poster presentations on innovative research conducted by addiction medicine clinical fellows, research fellows, and trainees. The event starts off with a plenary lecture by Dr. Chinazo Cunningham and is followed by an awards ceremony. 

Click here for event details.

Injectable hydromorphone treatment for severe opioid use disorder may reduce mortality and save costs to society compared to providing methadone alone, according to this study. 

The MSFHR Reach Program provides up to $10,000 in funding to support the dissemination and uptake of research evidence to inform and improve further research, practice and policy-making.